Emmanuel Y Jingwi1, Muneer Abbas2, Luisel Ricks-Santi3, Danyelle Winchester4, Desta Beyene5, Agnes Day1, Tammey J Naab6, Olakunle O Kassim7, Georgia M Dunston2, Robert L Copeland8, Yasmine M Kanaan9. 1. Cancer Center, Howard University, Washington, DC, U.S.A. 2. Department of Microbiology, Howard University, Washington, DC, U.S.A. Department of National Human Genome Center, Howard University, Washington, DC, U.S.A. 3. Cancer Research Center, Hampton University, Hampton, VA, U.S.A. 4. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, U.S.A. 5. Cancer Center, Howard University, Washington, DC, U.S.A. Department of Biochemistry, Howard University, Washington, DC, U.S.A. 6. Department of Pathology, Howard University, Washington, DC, U.S.A. 7. Department of Microbiology, Howard University, Washington, DC, U.S.A. 8. Department of Pharmacology, Howard University, Washington, DC, U.S.A. 9. Cancer Center, Howard University, Washington, DC, U.S.A. Department of Microbiology, Howard University, Washington, DC, U.S.A. ymkanaan@howard.edu.
Abstract
BACKGROUND/AIM: Several studies have revealed an association between single nucleotide polymorphisms (SNPs) in the VDR gene and prostate cancer (PCa) risk in European and Asian populations. To investigate whether VDR SNPs are associated with PCa risk in African-American (AA) men, nine VDR SNPs were analyzed in a case-control study. MATERIALS AND METHODS: Multiple and binary logistic regression models were applied to analyze the clinical and genotypic data. RESULTS: rs731236 and rs7975232 were significantly associated with PCa risk (p<0.05). In the analysis of clinical phenotypes, rs731236, rs1544410 and rs3782905 were strongly associated with high PSA level (p<0.05), whereas rs1544410 and rs2239185 showed a statistically significant association with high Gleason score (p<0.05). Haplotype analysis revealed several VDR haplotypes associated with PCa risk. Additionally, a trend existed, where as the number of risk alleles increased in the haplotype, the greater was the association with risk (p-trend=0.01). CONCLUSION: These results suggest that the VDR SNPs may be associated with PCa risk and other clinical phenotypes of PCa in AA men. Copyright
BACKGROUND/AIM: Several studies have revealed an association between single nucleotide polymorphisms (SNPs) in the VDR gene and prostate cancer (PCa) risk in European and Asian populations. To investigate whether VDR SNPs are associated with PCa risk in African-American (AA) men, nine VDR SNPs were analyzed in a case-control study. MATERIALS AND METHODS: Multiple and binary logistic regression models were applied to analyze the clinical and genotypic data. RESULTS:rs731236 and rs7975232 were significantly associated with PCa risk (p<0.05). In the analysis of clinical phenotypes, rs731236, rs1544410 and rs3782905 were strongly associated with high PSA level (p<0.05), whereas rs1544410 and rs2239185 showed a statistically significant association with high Gleason score (p<0.05). Haplotype analysis revealed several VDR haplotypes associated with PCa risk. Additionally, a trend existed, where as the number of risk alleles increased in the haplotype, the greater was the association with risk (p-trend=0.01). CONCLUSION: These results suggest that the VDR SNPs may be associated with PCa risk and other clinical phenotypes of PCa in AA men. Copyright
Authors: A R Baker; D P McDonnell; M Hughes; T M Crisp; D J Mangelsdorf; M R Haussler; J W Pike; J Shine; B W O'Malley Journal: Proc Natl Acad Sci U S A Date: 1988-05 Impact factor: 11.205
Authors: N A Morrison; J C Qi; A Tokita; P J Kelly; L Crofts; T V Nguyen; P N Sambrook; J A Eisman Journal: Nature Date: 1994-01-20 Impact factor: 49.962
Authors: Yue Xu; Atsuko Shibata; John E McNeal; Thomas A Stamey; David Feldman; Donna M Peehl Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-01 Impact factor: 4.254
Authors: Ingrid Oakley-Girvan; David Feldman; T Ross Eccleshall; Richard P Gallagher; Anna H Wu; Laurence N Kolonel; Jerry Halpern; Raymond R Balise; Dee W West; Ralph S Paffenbarger; Alice S Whittemore Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-08 Impact factor: 4.254
Authors: Robert L Copeland; Desta Beyene; Victor Apprey; Mohammad R Daremipouran; Tammey J Naab; Olakunle O Kassim; Yasmine M Kanaan Journal: Cancer Genomics Proteomics Date: 2017 Nov-Dec Impact factor: 4.069